Safety evaluation of jagua (genipin‐glycine) blue as a food additive
EFSA Journal · 2025-12 · 23 (12)
DOI: 10.2903/j.efsa.2025.9738 ↗Kurz gefasst
Fachartikel in der Zeitschrift EFSA Journal, 2025-12. Verfasst von EFSA Panel on Food Additives and Flavourings (FAF) und 29 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The EFSA Panel on Food Additives and Flavourings (FAF Panel) provides a scientific opinion on the safety of jagua (genipin‐glycine) blue as a new food additive. Jagua (genipin‐glycine) blue is obtained by water extraction of the ground pulp of the peeled, unripe fruits of Genipa americana L. and is the result of a reaction between genipin (iridoid present in the fruit) and externally added glycine. This reaction leads to the formation of a blue‐coloured polymer and minor colouring components. In vitro Caco‐2 cell permeability test demonstrated a low permeability of jagua (genipin‐glycine) blue, but repeated dose toxicity studies showed organs discoloration and green‐coloured urine, demonstrating some absorption. The toxicological data set comprised acute, sub‐chronic toxicity, genotoxicity studies and also a 12‐month toxicity study including in utero exposure. Jagua (genipin‐glycine) blue was not genotoxic, and no adverse effects were observed in the repeated dose toxicity studies up to the highest doses tested. The Panel derived an acceptable daily intake (ADI) of 34 mg/kg bw per day or 12 mg/kg bw per day expressed as blue polymer, based on a no observed adverse effect level (NOAEL) of 3385 mg/kg bw per day, the highest dose tested, from the 12‐month toxicity study and an uncertainty factor of 100. At the proposed maximum use level exposure assessment scenario, the 95th percentile of exposure approximately ranged from 1 mg/kg bw per day in the elderly to 27 mg/kg bw per day in toddlers. The Panel noted that both the mean and 95th percentile estimates of exposure did not exceed the proposed ADI in all population groups. The same was true for the exposure to the blue polymer assuming a 40% content in the proposed food additive. The Panel concluded there is no safety concern for jagua (genipin‐glycine) blue as a food additive at the proposed use and use levels.
Schlagwörter
Stichwörter der Autor:innen
Zitieren
APA
EFSA Panel on Food Additives and Flavourings (FAF), Castle, L., Andreassen, M., Aquilina, G., Bastos, M. L., Boon, P., Fallico, B., FitzGerald, R., Frutos Fernandez, M. J., Grasl-Kraupp, B., Gundert-Remy, U., Gürtler, R., Houdeau, E., Kurek, M., Louro, H., Morales, P., Passamonti, S., Barat Baviera, J. M., Degen, G., …, & Ruggeri, L. (2025). Safety evaluation of jagua (genipin‐glycine) blue as a food additive. EFSA Journal, 23(12). https://doi.org/10.2903/j.efsa.2025.9738
Vancouver
EFSA Panel on Food Additives and Flavourings (FAF), Castle L, Andreassen M, Aquilina G, Bastos ML, Boon P, et al. Safety evaluation of jagua (genipin‐glycine) blue as a food additive. EFSA Journal. 2025;23(12). doi:10.2903/j.efsa.2025.9738
BibTeX
@article{EFSAPanelonFoodAdditivesandFlavouringsFAF2025,
author = {EFSA Panel on Food Additives and Flavourings (FAF), EFSA Panel on Food Additives and Flavourings (FAF) and Castle, Laurence and Andreassen, Monica and Aquilina, Gabriele and Bastos, Maria Lourdes and Boon, Polly and Fallico, Biagio and FitzGerald, Reginald and Frutos Fernandez, Maria Jose and Grasl-Kraupp, Bettina and Gundert-Remy, Ursula and Gürtler, Rainer and Houdeau, Eric and Kurek, Marcin and Louro, Henriqueta and Morales, Patricia and Passamonti, Sabina and Barat Baviera, José Manuel and Degen, Gisela and Gott, David and Leblanc, Jean-Charles and Moldeus, Peter and Waalkens-Berendsen, Ine and Wölfle, Detlef and Civitella, Consuelo and Mech, Agnieszka and Medrano-Padial, Concepción and Tard, Alexandra and Zakidou, Panagiota and Ruggeri, Laura},
title = {Safety evaluation of jagua (genipin‐glycine) blue as a food additive},
journal = {EFSA Journal},
year = {2025},
volume = {23},
number = {12},
doi = {10.2903/j.efsa.2025.9738}
}
EUVIMED